Medial EarlySign helps healthcare systems with their early detection and prevention of high-burden diseases. Our outcome-focused software solutions (AlgoMarkers™) find subtle, early signs of high-risk patient trajectories in existing lab results and ordinary EHR data already collected in the course of routine care. EarlySign’s validated clinical risk predictors are rooted in deep expertise in Machine Learning. They provide clients the ability to identify early opportunities for proactive prevention, intervention with patients, and enhanced care management of high-burden, prevalent diseases.
From the essentials of data and analytics to the increasingly more complex applications of machine learning and artificial intelligence within healthcare, this is one event you don't want to miss.